Masimo Corporation

    Masimo Corporation

    NNASDAQ:MASI
    179.95
    USD
    0.00
    (0.00%)
    124.72P/E
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    9.65
    10.72
    12.28
    14.39
    15.34
    16.41
    17.55
    20.91
    22.46
    37.98
    24.16
    26.18
    28.49
    29.13
    Basic EPS, GAAP
    1.03
    1.33
    1.62
    6.28
    2.42
    3.7
    3.67
    4.39
    4.16
    2.68
    1.54
    -5.72
    -2.83
    1.43
    Free Cash Flow per Basic Share
    0.73
    0.3
    1.22
    7.97
    0.18
    4.15
    2.79
    2.4
    4.16
    -0.44
    0.61
    2.97
    3.6
    3.85
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    5.77
    5.82
    5.52
    11.16
    14.02
    18.25
    21.75
    25.48
    28.01
    25.5
    25.83
    19.63
    13.84
    15.07
    Tangible Book Value per Share
    4.87
    4.89
    4.56
    10.18
    13.1
    17.29
    20.83
    22.27
    24.89
    3.26
    5.77
    16.67
    10.9
    12.17
    Basic Weighted Avg Shares
    57
    55
    51
    50
    52
    52
    53
    55
    55
    54
    53
    53
    54
    54
    Sales/Revenue/Turnover
    547
    587
    630
    713
    790
    858
    938
    1,144
    1,239
    2,036
    1,276
    1,395
    1,527
    1,559
    Operating Margin (%)
    16.03
    15.88
    15.97
    23.28
    23.26
    24.29
    23.59
    22.32
    22.26
    10.32
    14.41
    4.55
    20.49
    19.86
    Depreciation Expense
    11
    13
    16
    17
    20
    21
    23
    29
    36
    136
    39
    49
    39
    38
    Net Income, GAAP
    58
    73
    83
    311
    125
    194
    196
    240
    230
    144
    82
    -305
    -151
    76
    Effective Tax Rate (%)
    26.42
    27.12
    29.95
    28.24
    32.84
    9.46
    16.21
    8.87
    16.33
    25.8
    4.69
    25.69
    23.81
    21.34
    Profit Margin (%)
    10.67
    12.36
    13.22
    43.64
    15.79
    22.55
    20.92
    21.01
    18.53
    7.05
    6.39
    -21.85
    -9.92
    4.9
    Working Capital
    168
    173
    167
    287
    430
    643
    824
    867
    971
    679
    668
    608
    554
    545
    LT Debt
    2
    125
    185
    - -
    - -
    - -
    16
    28
    26
    995
    918
    738
    545
    471
    Total Equity
    326
    308
    276
    560
    724
    969
    1,168
    1,408
    1,550
    1,339
    1,365
    1,052
    721
    789
    Return on Invested Capital (%)
    21.31
    17.62
    15.51
    21.51
    17.98
    22.06
    17
    17.46
    15.02
    7.71
    7.28
    2.24
    15.1
    16.4
    Return on Capital (%)
    20.15
    18.57
    19.04
    60.93
    19.5
    22.94
    18.22
    18.29
    15.2
    8.23
    5.38
    -13.22
    -8.16
    6.92
    Return on Common Equity (%)
    19.48
    22.93
    28.65
    74.46
    19.43
    22.86
    18.36
    18.66
    15.52
    9.93
    6.03
    -25.23
    -17.09
    8.79

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    ST Debt
    8
    14
    15
    LT Borrowings
    559
    518
    446
    LT Finance Leases
    19
    27
    26
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    54
    52
    52
    Market Capitalization
    7,925
    6,776
    9,314

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    Total Current Assets
    1,048
    926
    871
    Cash, Cash Equivalents & STI
    312
    152
    125
    Accounts Receivable, Net
    282
    261
    228
    Inventories
    339
    380
    400
    Total Current Liabilities
    370
    372
    325
    Payables & Accruals
    245
    230
    218
    ST Debt
    8
    14
    15
    Deferred Revenue
    38
    39
    37

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    15.14%
    -11.19%
    -31.44%
    Free Cash Flow
    276%
    27.69%
    22.14%
    Net Income, GAAP
    -31.7%
    -121.92%
    -50.31%
    Sales/Revenue/Turnover
    11.79%
    10.82%
    9.44%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    340
    344
    343
    601
    1,395
    2025
    372
    371
    372
    413
    1,527
    2026
    404
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    0.36
    0.3
    0.18
    -6.52
    -5.72
    2025
    -3.16
    0.94
    -1.86
    - -
    -2.83
    2026
    1.09
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business

    Company News

    • Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

    • IART vs. MASI: Which Stock Should Value Investors Buy Now?

    • IART or MASI: Which Is the Better Value Stock Right Now?

    • Masimo Shareholders Approve Acquisition by Danaher

    • Masimo SET Shows Accurate Pulse Oximetry in Newborns of All Skin Tones

    • DXCM or MASI: Which Is the Better Value Stock Right Now?

    • Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study

    • Masimo Corporation $MASI Shares Bought by Cwm LLC

    • Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Masimo Corporation $MASI

    • Apple Scores Key Win As Trade Commission Rejects Masimo's Bid To Reinstate Apple Watch Import Ban

    • Are MASI, CECO, MPX Obtaining Fair Deals for their Shareholders?

    • Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI

    • SG Americas Securities LLC Increases Stock Position in Masimo Corporation $MASI

    • Here Are Friday’s Top Wall Street Analyst Research Calls: Brown-Forman, Chord Energy, Emerson Electric, FuboTV, Genmab, Honeywell, Knight-Swift, Wix.Com, and More

    • This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition

    • Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?

    • Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?

    • This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement

    • Harbor Health Care ETF Q4 2025 Portfolio Review

    • American Century Companies Inc. Boosts Position in Masimo Corporation $MASI